NMRA - Neumora Therapeutics Inc Price Chart

Neumora Corp - graphic logo of issuer NMRA

Neumora Therapeutics (NMRA) possesses significant market influence in the field of precision neuroscience due to its personalized molecule selection. This price chart illustrates the asset's dynamics, where the current figure stands at 0.37. The business relies on big data analysis to create targeted therapies, which precludes dumping. However, investors should consider the high burn rate and the probability of failures in clinical trials.

Price Performance Chart: Neumora Corp (NMRA) for 02/21/2024 - 11/17/2026

Neumora Therapeutics Inc (NMRA) - metric breakdowns and financial figures

Analysis of all company metrics:neumoratx.com NMRA
Signature product of Neumora

To decouple fundamental stability from market noise, one must analyze the asset's value as a market consensus of the present value of future cash flows. By studying the price chart, an investor assesses the capitalization volatility of Neumora Therapeutics (NMRA), which directly reflects the market's confidence in the success of complex clinical trials amid high capital burn and fierce pharmaceutical competition.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|SCLX - Price Chart|Market Price Tevogen Bio|ACOG: Stock Price|CGTX - Market Chart|Price Chart Inhibikase Pharma|Price Chart SAVA|Stock Price ASRT|COYA (Coya Therapeutics) - Price Performance Chart|Price Chart vistagen.com VTGN|Ovid Therapeutics Inc. (OVID) - Market Price|Acumen Pharmaceuticals - Stock Price|Price Performance Chart CRVO (CervoMed Inc.)|ATHE (alteritytherapeutics.com) - Stock Quotes|CLNN - Market Chart|Stock Quotes PEPG|Stock Price jupiterneurosciences.com|Price Chart Relmada Therapeutics (RLMD)|ANVS (Annovis Bio, Inc.) - Price Performance Chart|Stock Price GRCE (Grace Therapeutics)|Firefly Neuroscience, Inc. (AIFF) - Market Price|Klotho Neurosciences - Stock Price|Market Price NeuroSense Therapeutics Ltd.|RVPH: Stock Price|MetaVia, Inc. (MTVA) - Stock Price|Stock Quotes NRXS|Helius Medical (HSDT) - Market Chart|Price Chart passagebio.com (PASG)|NEUP - Market Price|Price Chart Minerva Neurosciences, Inc. NERV|Market Chart Athira Pharma, Inc. (ATHA)|addextherapeutics.com - Stock Price|Market Chart alzamend.com ALZN|CYCN: Stock Price|PTIX: Price|Price Chart Pasithea Therapeutics Corp.|Stock Price cortigent.com|Stock Quotes ATXI (Avenue Therapeutics, Inc)|Stock Price Brainstorm Cell Therapeutics Inc. (BCLI)|Stock Price CARA (Cara Therapeutics Inc)|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel